Background
==========

Ischemic renal disease is a renal insufficiency associated with main renal artery stenosis or occlusion \[[@B1],[@B2]\]. Chronic ischemia causes progressive renal damage with atrophy and permanent loss of structural integrity. The cause-and-effect relationship between anatomic renal artery disease and renal function is often difficult to establish \[[@B3]\]. Deterioration of renal function derives not only from reduction in blood flow, but also from long term hypertension and concomitant risk factors like diabetes, hyperlipidemia, atheroemboli and aging \[[@B4]\].

Ischemic nephropathy has been recognized in the last decade as a distinct cause of renal insufficiency, especially in patients with advanced age \[[@B5]\]. A substantial percentage of patients with endstage renal failure which requires entering a dialysis program, is primarily affected by ischemic renal disease \[[@B6],[@B7]\]. Estimates of the prevalence of renovascular disease derive mainly from autopsy and angiographic studies of patients with renovascular hypertension or atherosclerotic disease involving other districts of the arterial tree \[[@B8]-[@B11]\]. Large population studies based on non invasive diagnostic methods are lacking.

The aim of this study is to evaluate the prevalence of renal artery stenosis in a relatively large population aged 50 and above, with arterial hypertension started over 50 years of age, or with chronic renal failure of late onset not explained by other diagnoses. The study is also aimed at comparing different diagnostic techniques for the detection of renal artery stenosis as well as clinical and biochemical indicators of renovascular disease.

Methods
=======

This study has been carried out on 269 patients, consecutively referred to the nephrologic outpatient clinic for arterial hypertension and/or chronic renal failure. Patients were selected according to the following criteria: age above 50 years, arterial hypertension starting after this age and/or chronic renal failure of late onset, with or without hypertension and unexplained by other known renal pathologies such as chronic glomerulonephritis, chronic tubulointerstitial disease, polycystic kidneys and obstructive renal disease. Diabetes mellitus was not an exclusion criterion and cases of suspected diabetic nephropathy were included when extrarenal atherosclerotic arterial occlusive disease coexisted. None of the patients was on dialysis treatment or had received a kidney transplantation.

269 patients, 150 males and 119 females, were characterized for clinical and standard biochemical parameters, as reported in Table [1](#T1){ref-type="table"}, and subjected to non invasive diagnostic manoeuvres, such as renal radionuclide scintigraphy and color-duplex ultrasonography of renal arteries. In particular, all 269 patients were studied either by color-flow duplex sonography (n= 238) or by renal scintigraphy (n= 224), and 199 of the 269 patients were evaluated using both of these techniques. 40 of 58 patients who were positive for renal artery stenosis with one or two techniques, underwent renal angiography either with three-dimensional contrast-enhanced Magnetic Resonance Angiography (3D-CE-MRA), and/or with Selective Angiography (SA). 7 of the remaining 18 patients could not be subjected to Magnetic Resonance Angiography because of technical problems (metallic prosthesis or pacemaker); 7 refused the procedure due to claustrophobia. In the remaining 4 cases, renal artery stenosis was on a small kidney. In particular, of 49 patients with a positive ultrasonography, 35 accepted to be submitted to renal angiography, while of 24 patients with a positive scintigraphy, 18 accepted to undergo renal angiography. In addition, 17 patients with negative results for renal artery stenosis with the non invasive manoeuvres, accepted to be submitted to Magnetic Resonance Angiography.

###### 

Clinical and laboratory data of the patient population (M ± SD;percent)

                                                                        normal values
  ------------------------------------------------------- ------------- ---------------
  Patient, n°                                             269           
  Sex, (M/F)                                              150/119       
  Age, years                                              65,8 ± 11,9   
  Weight, Kg                                              70,8 ± 11,9   
  Creatinine, mg/dl                                       1,7 ± 1       (0,6--1,2)
  Cr. Clearance, ml/min                                   54,8 ± 30,2   (90--120)
  Urea, mg/dl                                             61,2 ± 33,2   (10--45)
  Uric acid, mg/dl                                        6,5 ± 1,8     (3--7)
  Sodium, mEq/L                                           142 ± 4,3     (136--145)
  Potassium, mEq/L                                        4,6 ± 0,5     (3,6--5)
  Cholesterol, mg/dl                                      243 ± 53      (150--220)
  HDL cholesterol, mg/dl                                  49 ± 13,6     (\>45)
  Triglycerides, mg/dl                                    162 ± 83      (50--200)
  Urinary protein, mg/24 h                                654 ± 1103    (\<150)
  Systolic BP, mmHg                                       170 ± 25      (\<140)
  Diastolic BP, mmHg                                      96 ± 14       (\<90)
  Duration of hypertension, years                         7,5 ± 6       
                                                          n°            \%
  Arterial hypertension                                   238           88,5
  Familiar hypertension                                   113           42,0
  Smoking                                                 89            33,0
  Diabetes mellitus                                       42            15,6
  Hypertensive retinopathy (stage III and IV) (163/269)   4             2,5
  Interventricular septum (154/269)                       121           78,5
  Stenosis of epiaortic arteries (111/269)                60            54,0
  Stenosis of iliofemoral arteries (52/269)               33            63,5
  Renal dimensions asymmetry (\>11 mm)                    135           50,2

Doppler ultrasonography was carried out after fasting, following a three day of a low fibre diet and without smoking for a minimum of six hours before the procedure. Patients were studied with an Acuson 120 XP/4 (Acuson Corp., Mountain View, CA), equipped with a 3.5 MHz transducer, with longitudinal anterior, lateral and oblique approach, with at least threefold sampling of parameters along the artery. Subjects were asked to lie in the supine position for the study of the abdominal aorta and the origin of the renal arteries. Subsequently patients were turned on either side for the study of the renal arteries at the hilum and of parenchymal perfusion.

Standard criteria for the diagnosis of significant renal artery stenosis (≥ 60%) are \[[@B12]\]: 1. Systolic peak velocity above 180 cm/sec (sensitivity ![](1471-2369-4-2-i1.gif) 94%, or 98% when peak velocity \>200 cm/sec). 2. Renal aortic ratio, defined as the ratio between systolic peak velocity in the renal artery and systolic peak velocity in the abdominal aorta in the suprarenal tract, with a normal value of \<3.5.

Renal radionuclide scintigraphy was performed with a gamma camera (Starcam 4000, General Electric, USA) with ^99m^Tc-DTPA (diethylenetriaminepentaacetic acid) in 125 patients and with ^99m^Tc-MAG3 (mercaptoacetyltriglycine) in 99 patients, with a total of 224 patients. MAG3 was chosen in patients with creatinine clearance \<25 ml/min. Diuretics and/or ACE inhibitors were discontinued at least three days before, if treatment was underway. Criteria of positivity for renal artery stenosis were: Parenchymal transit time \>4 minutes; a difference in split renal function \>30%; T~max~\>5 min, with a difference between kidneys \>1 min. A captopril test was carried out in 161 patients, by administering captopril 50 mg p.o. one hour before the administration of the tracer. Following captopril administration, criteria of suspected stenosis were: with ^99m^Tc-DTPA, a fall in glomerular filtration rate of the affected side \>5%; with ^99m^Tc-MAG3, an increase of at least 0.15 of the 20 minutes/peak count ratio (ratio between the activity after 20 minutes and peak radioactivity); or a lengthening of \>2 min of T~max~value, or a delay of tracer elimination in the pelvis of \>2 minutes \[[@B13],[@B14]\].

Magnetic Resonance Angiography was performed with a 1.5 T magnet (Vision Plus; Siemens, Erlangen, Germany) with 25 mT/m gradient strengtth and 600 microseconds gradient rise time. In all cases a Flash 3D T1-weighted sequence (TR = 4.6; TE = 1.8, FA = 30°, NEX = 1, Slab thickness = 120, FOV = 500, matrix = 200 × 512, n° partitions = 34) was used. The acquisition time of the sequence was 23 s. A phased array body coil was used. Before the acquisition a test bolus was performed (TR = 5.8, TE = 2.4, FA = 10, Thickness = 10, matrix-128 × 256, FOV = 400, NEX = 40), injecting 2 ml of Gd-DTPA at 2 ml/s; in order to establish the correct delay time. The examination was performed administering 0.2 mmol/kg of Gd-DTPA with a power injector (Spectris, Medrad) at a flow rate of 2 ml/s. Images were reconstructed using a standard maximum intensity projection (MIP) algorithm and were reviewed by two radiologists obtaining a final report by consensus. This is a more advanced technique than TOF-MRA (Time of Fly) and PC-MRA (Phase-Contrast), and is especially useful for detection of renal artery stenosis. It is considered to have specificity and sensitivity values approaching selective angiography \[[@B15],[@B16]\].

MR angiography was carried out in a total of 39 patients, 22 with positivity of at least one of the non invasive manoeuvers, and 17 cases with negative results. Selective angiography was carried out in 32 patients among those with at least one positivity for renal artery stenosis, diagnosed with non invasive techniques. Stenosis was considered significant both with MRA and SA when at inspection the reduction in arterial lumen diameter was ≥ 60%. In 14 patients, both MRA and SA were performed. The presence of renal artery stenosis, identified by MRA, was confirmed in all cases by SA. The total number of angiographic studies was 57.

Statistical analysis
--------------------

Following a preliminary descriptive analysis, since the available data did not allow to evaluate sensitivity and specificity, contingency tables were created only for evaluation of positive and negative predictive values for the diagnostic techniques,. For each index the confidence interval at 95% level was calculated. Mann-Withney non parametric and Pearson χ^2^tests were used. Significance threshold level was considered to be p \< 0.05.

Results
=======

The number of patients, sex distribution, average age, blood pressure values and several biochemical parameters for the entire population together with other clinical parameters of the population are reported in Table [1](#T1){ref-type="table"}.

The population was found to have, on average, a moderate renal insufficiency, as shown by the mean creatinine clearance of 54.8 ± 30.2 ml/min. 88.5% of the patients had arterial hypertension. Hypertensive organ damage was evidenced by a thickening of interventricular septum in 78.5% of cases, revealed by echocardiography. In addition, on average the patients had increased cholesterol levels. Carotid and lower extremities artery stenosis were found in 54% and 63% respectively, of the patients studied. Diabetes mellitus was present in 15.6 %.

A synopsis of the results of the non-invasive techniques is reported in Table [2](#T2){ref-type="table"}. Renal color-duplex sonography, performed in 238 patients, showed that 49 (20.6%) were affected by renal artery stenosis. MRA and/or SA were performed in 35 of these 49 patients. The diagnosis was confirmed in 33 cases, while 2 cases were false positive. 23 of 189 patients with a negative result of color-duplex sonography, accepted to undergo a renal angiography. In 20 cases the angiography confirmed the negativity, while 3 cases were found to be false negative. On the basis of these data the positive predictive value of color-duplex sonography was 94.3% (80.8--99.3% Confidence Interval) and the negative predictive value was 87.0% (66.4--97.2% C.I.).

###### 

Synopsis of results of non-invasive techniques

              **DDS**              
  ----------- --------- ----- ---- -----
  Pos         22        0     2    24
  Neg         27        150   23   200
  No tested   0         39    6    45
                                   
  All         49        189   31   269

Renal scintigraphy was carried out in 224 patients. 24 patients had a positive test for renal artery stenosis. 18 of 24 patients underwent an angiography. Positivity for renal artery stenosis was confirmed in 13, while 5 cases were false positive. Of 200 cases with negative results, 17 were further examined with angiography; 12 of these cases were false negative. The positive predictive value was 72.2% (46.5--90.3% C.I.), while the negative predictive value was 29.4% (10.3--56.0% C.I.).

The comparison between patients with and without renal artery stenosis (Table [3](#T3){ref-type="table"}), based on the results of color-duplex sonography, has shown significant difference in the extent of renal failure. The levels of proteinuria did not reach statistical difference probably due to the groups sizes. Significant difference was also found in the prevalence of renal asymmetry and in percent of patients with diabetes mellitus (Table [3](#T3){ref-type="table"}). 59% of the patients had a unilateral stenosis while it was bilateral in 41%. The comparison of renal damage between patients with unilateral and bilateral renal artery stenosis in reported in Table [4](#T4){ref-type="table"}.

###### 

Humoral parameters (M ± SD) and percentage of clinical findings in patients with and without renal arterial stenosis

  --------------------------------------------- -------------- ------------- ----------
                                                **with**       **without**   **P**
                                                                             
  Patient, n°                                   49             189           
  Age, years                                    68,1 ± 8       66,3 ± 8,9    0,18
  Creatinine, mg/dl                             2,5 ± 1,5      1,6 ± 0,06    \<,00001
  Cr. Clearance, ml/min                         34, 7 ± 19,2   58,2 ± 30,8   \<,00001
  Urea, mg/dl                                   84 ± 38        57 ± 29       \<,00001
  Uric acid, mg/dl                              6,9 ± 1,8      6,4 ± 1,8     0,07
  Sodium, mEq/L                                 142 ± 4,9      142,2 ± 4     0,6
  Potassium, mEq/L                              4,6 ± 0,5      4,5 ± 0,4     0,52
  Cholesterol, mg/dl                            236 ± 58       229 ± 54      0,15
  HDL cholesterol, mg/dl                        45,6 ± 12      49,6 ± 12     0,06
  Triglycerides, mg/dl                          176 ± 74       156 ± 76      0,08
  Urinary protein, mg/24 h                      659 ± 672      595 ± 980     0,14
  Systolic BP, mmHg                             175 ± 29       166 ± 21      0,07
  Diastolic BP, mmHg                            93 ± 15        94 ± 13       0,44
                                                \%             \%            
  Smoking                                       28,4           31,8          ns
  Diabetes mellitus                             29,8           13,6          \<,01
  Hypertensive retinopathy (stage III and IV)   6,1            6,1           ns
  Interventricular septum                       88,0           74,5          ns
  Stenosis of epiaortic arteries                30,0           15,2          ns
  Stenosis of iliofemoral arteries              57,1           50,0          ns
  Renal dimensions asymmetry (\>11 mm)          75,6           43,9          \<,001
  --------------------------------------------- -------------- ------------- ----------

###### 

Comparison of renal damage between patients with mono-and bilateral renal arterial stenosis.

  -------------------------- ------------- ------------- ------
                             monolateral   bilateral     P
                                                         
  Creatinine, mg/dl          2,4 ± 1,5     3.0 ± 1,8     0,22
  Cr. Clearance, ml/min      41,2 ± 21,9   29,6 ± 16,5   0,15
  Urea, mg/dl                76.0 ± 46,4   97,6 ± 36,5   0,08
  Urinary protein, mg/24 h   575 ± 627     469 ± 329     0,7
  -------------------------- ------------- ------------- ------

Renal artery stenosis was found in 11.1% of patients in the 50--59 age group, in 18% in the decade 60--69 and 23% of patients above 70 years of age.

Discussion
==========

The primary aim of this study is to evaluate the diagnostic role of the non invasive approach to renal artery stenosis and ischemic nephropathy in the elderly, to compare the clinical and biochemical data of patients with and without ischemic nephropathy and to establish the prevalence of this disease among the selected population in the different decades of life.

Based on a comparison between non invasive techniques such as renal scintigraphy and color-duplex sonography, and the diagnostic gold-standard of arteriography, that is both Magnetic Resonance and/or Selective Angiography, we attempted to assign predictive values to these non invasive techniques. There is sufficient agreement between MRA and SA to combine the outcomes for use as a goldstandard. The good agreement was probably due at least in part to the particular sensitivity and specificity of the MR technique utilized in this study, which is considered superimposable to selective angiography \[[@B15]-[@B17]\], at least for the stenosis at the origin or at main renal artery. All our cases tested with both arteriographic techniques had comparable results as far as the presence of renal artery stenosis is concerned. The identity of results has been reported by De Cobelli et al. \[[@B18]\] and by Ghantous et al \[[@B15]\].

There are some limitations in the use of Magnetic Resonance, such as claustrophobia and the presence of pacemakers or metallic prosthesis. Since Magnetic Resonance is generally not employed on a routine basis for screening purposes in large populations due to cost and availability, the less expensive non-invasive imaging techniques should come first in the preselection of affected patients.

In the comparison between color-doppler sonography and radionuclide scintigraphy, unfortunately based on a limited number of patients, the former was apparently clearly superior in terms of positive and negative predictive values, in agreement with data of the literature \[[@B19]\]. However this technique requires an experienced operator in order to reach high levels of reliability. On the other hand, in screening for ischemic nephropathy, among patients with renal insufficiency, radionuclide scintigraphy was clearly less reliable, either using DTPA or MAG3. This technique may give better results in terms of sensitivity and specificity in a population screened for renovascular hypertension, in general with normal renal function. Scoble et al \[[@B19]\] have underlined that radionuclide scintigraphy may give better results in the screening of renal artery fibrous dysplasia, where hyperreninism is more frequent, while it is of lower diagnostic value in the diagnosis of renal ischemia.

Comparing patients with and without renal artery stenosis in an elderly population, a higher grade of renal insufficiency in patients with renal artery stenosis emerged clearly, whether the stenosis was unilateral (59%) or bilateral (41%). Renal insufficiency was found in both groups (Table [4](#T4){ref-type="table"}). Therefore renal artery stenosis in the elderly is associated to atherosclerotic vascular involvement of both kidneys, with bilateral damage to renal function. It is misleadingly simplistic to consider the overall renal damage as deriving from reduced blood perfusion of the kidney, due to renal artery stenosis. The poor correlation existing between the extent of renal artery stenosis and degree of renal insufficiency has been reported previously \[[@B3],[@B20]\]. As for arterial hypertension, no difference was found between stenotic and non stenotic patients (Table [3](#T3){ref-type="table"}).

The observation concerning proteinuria is also of interest. The extent of proteinuria did not seem to differ between patients with and without renal artery stenosis, probably due to the given groups sizes. Therefore the exclusion of patients with proteinuria higher than 500 mg/day from further diagnostic procedures for renal artery stenosis, appears to be unjustified \[[@B21],[@B22]\]. More recently the occurrence of marked proteinuria in patients with ischemic nephropathy has been reported \[[@B23],[@B24]\]. Therefore our data support the hypothesis that atherosclerotic renal involvement may be accompanied by pathologic proteinuria. On the other hand heavy proteinuria is of frequent occurrence in nephroangiosclerosis, focal glomerulosclerosis and cholesterol emboli, conditions found in ischemic nephropathy \[[@B25]-[@B27]\] among the elderly.

The data of the medical literature on the prevalence of ischemic renal disease in the elderly are scarce, derived mainly from autoptic findings or from arteriography studies performed for coronary artery disease \[[@B7]-[@B10]\]. Our results based on color-duplex ultrasonography findings indicate an elevated occurrence of this disease in this cohort, with an increasing prevalence from the sixth decade, and reaching above 20% after age 70. Therefore the presence of ischemic nephropathy should be considered in elderly patients affected by unexplained renal insufficiency and/or hypertension of late onset. The possible evolution towards further deterioration of renal function in patients with renal artery stenosis and the results of relatively non-invasive renal stenting procedures for prevention and treatment, are indication for an extensive screening of at risk subjects.

Competing interests
===================

None declared

Authors\' contributions
=======================

1\. GC conceived and coordinated the study

2\. SC clinical work

3\. SL expert in DDS

4\. EM clinical work and participation in design of the study

5\. IN biostatistical work

6\. GR carried out renal scintigraphy

7\. MR magnetic resonance performance

8\. GV collaboration in renal scintigraphy

9\. DS clinical laboratory work

10\. MF clinical work and assistance in coordination

11\. AZ endovascular surgery and selective angiography

12\. RC DDS expert

Pre-publication history
=======================

The pre-publication history for this paper can be accessed here:

<http://www.biomedcentral.com/1471-2369/4/2/prepub>

Acknowledgements
================

The study was supported by funds of La Sapienza University. The skillful contribution of Ms. Antonina Scuderi is acknowledged
